Search / Trial NCT00001734

Screening for NEI Clinical Studies

Launched by NATIONAL EYE INSTITUTE (NEI) · Nov 3, 1999

Trial Information

Current as of December 26, 2024

Completed

Keywords

Uveitis Conjunctivitis Iritis Retinitis Keratitis Screening Protocol Ocular Immunology Inflammation Eye Inflammation

ClinConnect Summary

This protocol is designed for the screening of patients with either diagnosed or undiagnosed conditions, and serves as a first step for individuals who may be eligible, and wish to participate in NEI- National Eye Institute clinical research studies.

Each individual will be thoroughly evaluated during the screening process to determine if they are suitable candidates for inclusion in any of the NEI ongoing studies. The screening evaluation will include past and current medical histories, and an appropriate physical examination. Other routine diagnostic procedures and tests may also be comp...

Gender

ALL

Eligibility criteria

  • * Participants will be able to enroll if they:
  • 1. Have a diagnosed ocular inflammatory eye disease; OR
  • 2. Have an unusual, interesting or unknown ocular condition that requires the establishment of a diagnosis; AND
  • 3. Have the ability to understand and sign an informed consent OR have a legal parent/guardian with the ability to do the same.
  • 2.2 Exclusion Criteria
  • Participants will be unable to enroll if they:
  • 1. Have no ocular medical conditions; OR
  • 2. Are unwilling or unable to cooperate with the procedures.

About National Eye Institute (Nei)

The National Eye Institute (NEI), part of the U.S. National Institutes of Health (NIH), is dedicated to conducting and supporting innovative research to understand, prevent, and treat eye diseases and vision disorders. As a leading sponsor of clinical trials, NEI aims to advance knowledge in ocular health through rigorous scientific inquiry and collaboration with researchers, healthcare professionals, and institutions. By fostering the development of new therapies and technologies, NEI plays a pivotal role in enhancing the quality of life for individuals affected by visual impairments and eye conditions.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials